Investment Q&A

Q: Can you please comment on E's recent Q and it's future prospects. Jason Donville at DKAM sees it as a potential multibagger and I am wondering if this is one of his rare misses or if he is just a little early.

Thanks
Scott

Q: This stock is up 50% in less than a month and is at a 52 week high it also will be making about 270 million going forward this year. They get to keep 90% of that. My simple math has them at a P/E of 6.4 on a forward basis if they don’t overachieve. There drug is getting traction into the hospitals and with the doctors due to its drug profile.

Aurina has another drug in the pipeline going into phase two that looks good and I hope they go after rheumatoid arthritis. To me everything looks good here. This is my fun stock to stop me from becoming too bored and is finally becoming exciting.

What do you folks think is going on here regarding the big move in the stock price and where it could go. Looks like the existing drug revenue tops out an around 600 million annually.

Q: Your thoughts on this stock and whether it is a buy / good bet at this price would be helpful.

Q: How can I invest in AI or companies that are heavily using AI ?

Q: Some of my shorts, (DE, JBHT and DRI) are reacting well in the pre-market. Do you think they are worth holding, as shorts, for a while yet? Can you comment in particular on DE's earnings? Thank-you.

Q: Please name your top 4 companies that are into ART. Intelligence A/I. Brief reason for each pick. Take as many credits as necessary. Thanks. Helen

Q: Please comment on 2nd results.

Thank you

Q: Hello
What is your view on Fulgent Genetics? Thanks for your advice.

Q: Is there anywhere on your website that I can create a portfolio and monitor its performance?

Sheldon

Q: Please comment on results, outlook, and the jump in share price. Can it climb higher?

Q: Peter; LGN has traded over 2M shares today- was it block trades - any idea, besides their earnings report, on why this size of trading? Thanks.
Rod

Q: Thoughts on DEFI Q2 earnings and raised guidance and is this a good entry point?

Q: Can you please evaluate the results from GAMB? What was good and what was bad? Why the big sell off? Lastly, buy, sell or hold and why please. I own a small piece of this along with SRAD and GENI and am baffled at its underperformance.

Separately, what do you think of Keystone Financial (key stocks.com) as as supplementary service to 5i? Does coverage overlap dramatically or could it be a nice secondary source of potential growth stocks?

Thanks

Thanks!

Q: Your thoughts on recent earnings and prospects going forward given Canada's infrastructure plans.

Q: I have been reading about "Stablecoins" in recent articles re Crypto. Do you see Stablecoins replacing cash as official currencies around the world? How much , in your estimation, do you see the Genius Act, the bipartisan bill recently passed in congress, will it effect the financial world as we know it?

Q: Good Day team:How did PRL get ranked along with LMN so far down the line for today. I Recently paid 35.50 for PRL based on 5i's high regard for this name. Should I dump it .Looks like it could be headed for it's 52 week low.Your thoughts please .Larry

Q: In January you noted:

We are mixed here. We don't like the leverage and the sector may still be weak under Trump policies (solar).

What's changed since then that made you come around to it and add it to your growth portfolio in July?

Q: Hello, would like to know for total returns of these ETFs (ZWC, ZWU, CNCC, HCAL, ZSP, VCN, VE, XGRO, VEQT, XBAL) which is your favorite in order for each and in which account type is each best suited for. Also please give me your number 1 top pick of all Canadian listed ETFs for each account type.

Thank you

Q: What is your opinion on the new All In One Income ETFs such as HHIS,FFIX and FCIP. I realize that they are all relatively new but do you think they are a good investment at this time?

Q: In response to Terry's question this morning is it BAM or BN that's splitting 3/2 this October?

Thanks David